Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01163266

Public ClinicalTrials.gov record NCT01163266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 20 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

Study identification

NCT ID
NCT01163266
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
462 participants

Conditions and interventions

Interventions

  • Vortioxetine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Dec 17, 2013

2010 – 2012

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Not listed Anaheim California
Not listed Cerritos California
Not listed Costa Mesa California
Not listed Encino California
Not listed Garden Grove California
Not listed Irvine California
Not listed Pico Rivera California
Not listed Riverside California
Not listed Colorado Springs Colorado
Not listed Norwich Connecticut
Not listed Maitland Florida
Not listed North Miami Florida
Not listed Orange City Florida
Not listed Orlando Florida
Not listed St. Petersburg Florida
Not listed Smyrna Georgia
Not listed Chicago Illinois
Not listed Joliet Illinois
Not listed Skokie Illinois
Not listed Wichita Kansas
Not listed Lake Charles Louisiana
Not listed Worcester Massachusetts
Not listed Saint Charles Missouri
Not listed St Louis Missouri
Not listed Willingboro New Jersey
Not listed Buffalo New York
Not listed New York New York
Not listed Rochester New York
Not listed Cinti Ohio
Not listed Dayton Ohio
Not listed Middleburg Heights Ohio
Not listed Portland Oregon
Not listed Norristown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Charleston South Carolina
Not listed Irving Texas
Not listed Richmond Virginia
Not listed Seattle Washington
Not listed Brown Deer Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01163266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01163266 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →